Medical Network October 21, in the global medical robot market share, European and American companies almost dominated, domestic entrepreneurial teams are mostly one or two people, which increases the risk of product development Source: First Financial Daily Eas anti-theft antenna is mainly suitable for large supermarkets, shopping malls, bookstores, audio stores with Security hard tags, rf soft label, AM lable,Pin and Lanyard, eas detacher, Hook Lock,EAS Self Alarm Tag, EAS Safer Box,etc. WENZHOU BOSHINE ELECTRONIC SECURITY CO.,LTD , https://www.boshine.com
:2016-10-24
Domestic medical robot companies have taken a step closer to achieving product scale.
“The nurses are screaming, the robot nurses are their idols, they have to take photos with them.†Recently, Ren Yuxiang was unable to help the reporter of the “First Financial Daily†when describing the latest development of a robot in Shenzhen’s hospital. smile.
Ren Yuxiang is a nurse at Peking University Shenzhen Hospital. Before the "Eleventh" holiday this year, the hospital and the company jointly developed two intravenous drug configuration robots for actual measurement. The shape of this nursing robot is not so "cool and cute", but it is specially formulated with tumor drugs that have strong volatility and can be poisoned by accidental use. It’s almost a month, and the nurses are still excited to see this robot that may free them from dangerous work in the future.
At present, in the global market share of medical robots, European and American companies are almost monopolizing. In China, medical robots are still in the stage of research and development or clinical trials, and cases of achieving product scale have hardly been seen. However, in the past two years, the industry has ushered in the spring of policy, and the pace of enterprises entering the market is accelerating.
The manufacturer of the above-mentioned robot, Shenzhen Bowei, the general manager of Medical Robot Co., Ltd., told the reporter that “Peking Shenzhen Hospital is our first pilot hospital and is still optimizing, waiting for the feasibility report, plan two Enter the market after three months."
Let the nurse get out of danger
Chemotherapy drugs used to treat tumors are highly toxic after volatilization. Every time the nurses enter the dispensing room, they are fully armed, wearing thick protective clothing, gloves, masks and goggles to wrap the whole body up and down.
Even so, it is difficult to ensure complete isolation of the human body and drugs. Ren Yuxiang said: "It is two or three hours or even half a day. Because it is too dense, there is something urgent in the middle." Because of the fear of the toxicity of chemotherapy drugs, even if it is sprinkled a little bit, it will damage the skin. Be careful.
"And these chemotherapeutic drugs are all waiting for patients to save lives. They dare not make a little mistake. Over time, there are obsessive-compulsive symptoms. Sometimes the bottles are thrown into the trash after the medicine is finished, and they have to look up. See if the pairing is correct." Ren Yuxiang said.
From this point of view, the probability of a nurse's error is almost zero: in addition to strictly proportional to the dispensing, in the event of an error, it will automatically sound an alarm. In the future, after the robot is officially put into clinical use, the nurses will be freed from the busy and trivial work, and have more energy and time to take care of the patients.
According to the introduction of the ocean, the intravenous dosing robot still needs people to operate, but the person is standing outside the fully enclosed device, and the dispensing is automatically carried out in the device. On average, one machine can be used for one to three minutes, one machine can be used with up to 10 bottles of medicine, and one person can operate three to four machines.
According to his understanding, there are currently four or five robots in the same field in China, and only one of them has entered the market, and others are in the research and development stage.
Medical robots are heavily resistant
Medical robots are standing on the cusp of policy. In May 2015, the “Made in China 2025†strategy was issued, which required “to vigorously promote breakthrough development in key areasâ€. The top ten areas mentioned included high-performance medical devices , one of which was to focus on the development of high-performance medical equipment such as medical robots.
At present, the classification of medical robots is not uniform, but a common method is to include surgical robots, rehabilitation robots, and mobile robots in addition to the above-mentioned nursing robots. Among them, the surgical robot industry is the most risky and the most rewarding.
According to our reporter, the most common surgical robots are general surgery, brain surgery, obstetrics and gynaecology and orthopedics in large hospitals. Among them, "Da Vinci" for minimally invasive laparoscopic surgery is one of the most successful representatives of commercialization.
Since the advent of the United States 20 years ago, "Da Vinci" has undergone several generations of changes, now mainly used for minimally invasive laparoscopic surgery in cardiac surgery, urology, gynecology, etc., assisting doctors to observe the structure and details of the lesion in multiple directions, surgery The movement is more stable and fine, and the wound is small.
However, the biggest obstacle to the promotion of high-end medical devices such as Da Vinci in China is the high cost of surgery. Wang Peijun, a partner of Oriental Fuhai and a health care fund manager, told this reporter: "The introduction of a set of Da Vinci's surgical operation platform is more than 10 million yuan, and a single surgical consumable set of 20,000 to 40,000 yuan."
He added: "The industry is generally optimistic about the prospects of surgical robots, the key is whether the cost can be effectively controlled. At present, the solution of some enterprises at home and abroad is a simple version of the surgical robot, the goal is to reduce the operation while maintaining the quality of surgery. The manufacturing cost and price of the robot, while also reducing the cost of consumables."
In addition to surgical robots, Wang Peijun is also optimistic about automated machinery or robots in the fields of rehabilitation and nursing.
However, it is always a tortuous road with the wonderful prospects. At present, domestic hospitals are not willing to buy robots in the fields of rehabilitation and nursing.
Taking rehabilitation robots as an example, Tian Wei, dean of Beijing Jishuitan Hospital, told the reporter of China Business News that it is difficult for rehabilitation robots to do it because there are too few patients who go to the hospital for treatment, and those who are willing to pay for this robot are not many. In addition, national policies are not expensive for rehabilitation projects, and hospitals are reluctant to invest large amounts of money.
Not only that, in the view of Sang Hongxun, director of the Department of Orthopaedics, Shenzhen Medical University, Southern Medical University, these robots can only do some labor mechanically, and the work done is limited. The depth and breadth of degrees of freedom and artificial intelligence are difficult to compare with people. "And, the robot just answers some fixed questions. If the patient asks an unconventional question, it can't answer it, and it is difficult to give the patient a humane care."
"But there is no doubt that medical robots represent a new direction." Sang Hongxun told this reporter.
Can it become an investment outlet after 5 years?
At present, the vast majority of medical robot companies in China are still in the stage of research and development or clinical trials, and almost no cases of industrialization have been disclosed. Most of the VCs are watching closely, and they have not been intensively shot.
At the end of last month, Wang Shuxin, director of the Tianjin University-Weigao Medical Robot Joint Research Center, said at an academic forum in Shenzhen that five years later, the investment boom of industrial robots will slowly recede and turn to medical robots.
According to Ren Junzhao, the investment director of Dachen Venture Capital, the scope of the tilt should be extended to service robots other than non-industrial robots. He told this reporter: "After five years, industrial robots will be relatively mature, so growth will be affected; investment tide will also fade, and then look for new areas."
Some VCs also believe that considering the difficulty of research and development, 5 years is still shorter.
Wang Peijun told the “First Financial Daily†reporter: “The development of medical robots requires collaboration among clinicians, electronic engineers, materials engineers, mechanical engineers, etc. There are many foreign entrepreneurs , and one team may include clinicians and multiple fields. Most of the engineers are asking for the needs and pain points by the clinician. The solution is proposed by several engineers. After several rounds of modification and improvement, they are gradually shaped."
In recent years, he has been paying attention to the investment in surgical robots. In addition to domestic companies, he has also gone to Israel and other countries to understand the industry dynamics and look for possible investment opportunities. “The domestic entrepreneurial team is mostly one or two people, and the inter-disciplinary and cross-disciplinary entrepreneurial collaboration atmosphere is relatively lacking.†He added, “Once there is a fatal flaw in product design, it is a disaster for entrepreneurs, and this is also an investor. The main concern."